logo


Insulet Corporation to Present at Upcoming Investor Conferences
Tuesday, May 05, 2009 4:15 PM


BEDFORD, Mass., May 5 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the leader in tubing-free insulin pump technology with its OmniPod(R) Insulin Management System, today announced the company will participate in upcoming investor conferences. These conferences include:

  • The Canaccord Adams Diabetes & Obesity Conference taking place May 12, 2009 at the InterContinental Barclay Hotel in New York, NY. Management is scheduled to present an overview of the Company on Tuesday, May 12, 2009 at 3:00 p.m. EDT.
  • The Bank of America and Merrill Lynch 2009 Health Care Conference taking place May 12-14, 2009 at the Palace Hotel in New York, NY. Management is scheduled to present an overview of the company on Wednesday, May 13, 2009 at 4:00 p.m. EDT.
  • The Eighth Annual JMP Securities Research Conference taking place May 18-20, 2009 at The Ritz-Carlton Hotel in San Francisco, CA. Management is scheduled to present an overview of the Company on Tuesday, May 19, 2009 at 1:30 p.m. PDT.
  • The 29th Annual William Blair Growth Stock Conference taking place June 9-11, 2009 at The Four Seasons Hotel in Chicago, IL. Management is scheduled to present an overview of the Company on Tuesday, June 9 at 10:10 a.m. CDT.

During these conference presentations, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the audio webcast of these presentations during the event, please visit: http://investors.insulet.com. A replay of each webcast will be available for 30 days.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Contact:
    Stephanie Marks for Insulet Corporation
    ir@insulet.com
    877-PODD-IR1 (877-763-3471)

SOURCE Insulet Corporation

(Source: PR Newswire )


(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia